IGF2BP2, an m6A binding protein that enhances the stability and translation of mRNA, is highly expressed in acute myeloid leukemia AML cells and promotes leukemia progression by regulating the expression of MYC. Here, IGF2BP2 is linked to acute myeloid leukemia.